Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis.
Emma L LedgerDaniel J SmithJing Jie TehMichelle E WoodPage E WhibleyMark MorrisionJoanna B GoldbergDavid W ReidTimothy J WellsPublished in: The Journal of infectious diseases (2024)
Despite the clinical benefits of CFTR modulators, clonal lineages of P. aeruginosa persist that may prove just as difficult to manage in the future, especially in pwCF with advanced lung disease.